Berger Dietmar 4
4 · GILEAD SCIENCES, INC. · Filed Jan 3, 2025
Insider Transaction Report
Form 4
Berger Dietmar
Chief Medical Officer
Transactions
- Award
Restricted Stock Unit
2025-01-02+48,975→ 48,975 total→ Common Stock (48,975 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a three year vesting schedule. 33.33% will vest on the anniversary of the date of grant until fully vested.